Literature DB >> 8873434

Immunologic tolerance in renal transplantation.

D A Shoskes1.   

Abstract

The current excellent short-term results of renal transplantation are achieved at the expense of complications of chronic immunosuppression. These include increased risk for infection, malignancy, and long-term deterioration of function ("chronic allograft nephropathy"). The induction of transplantation tolerance, the long-term acceptance of an allograft without continuous immunosuppression, has been a goal of transplant immunologists for the last 40 years. Unfortunately, this has been easier to achieve in rodents than in humans. Nevertheless, this body of research has significantly increased our knowledge of the workings of the immune system and specifically, how the body differentiates between "self" and "nonself". Using these insights, several promising approaches to the clinical induction of transplant tolerance have emerged and are undergoing clinical evaluation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8873434     DOI: 10.1007/bf00182070

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  88 in total

1.  The effectiveness of pretreatment with soluble or membrane-bound donor class I major histocompatibility complex antigens in the induction of unresponsiveness to a subsequent rat renal allograft.

Authors:  S Foster; K J Wood; P J Morris
Journal:  Transplantation       Date:  1992-06       Impact factor: 4.939

2.  Renal allograft rejection. Tubular epithelial cells present alloantigen in the presence of costimulatory CD28 antibody.

Authors:  J L Wilson; G Proud; J L Forsythe; R M Taylor; J A Kirby
Journal:  Transplantation       Date:  1995-01-15       Impact factor: 4.939

3.  Immunological unresponsiveness induced by recipient cells transfected with donor MHC genes.

Authors:  J C Madsen; R A Superina; K J Wood; P J Morris
Journal:  Nature       Date:  1988-03-10       Impact factor: 49.962

4.  Induction of donor-specific tolerance to cardiac but not skin or renal allografts by intrathymic injection of splenocyte alloantigen.

Authors:  Y Nakafusa; J A Goss; T Mohanakumar; M W Flye
Journal:  Transplantation       Date:  1993-04       Impact factor: 4.939

5.  Interaction between T lymphocytes and kidney epithelial cells during renal allograft rejection.

Authors:  J A Kirby; M R Rajasekar; Y Lin; G Proud; R M Taylor
Journal:  Kidney Int Suppl       Date:  1993-01       Impact factor: 10.545

6.  Mechanisms of acquired thymic unresponsiveness to renal allografts. Thymic recognition of immunodominant allo-MHC peptides induces peripheral T cell anergy.

Authors:  M H Sayegh; N Perico; L Gallon; O Imberti; W W Hancock; G Remuzzi; C B Carpenter
Journal:  Transplantation       Date:  1994-07-27       Impact factor: 4.939

7.  The assessment of transplantation tolerance induced by anti-CD4 monoclonal antibody in the murine model.

Authors:  T C Pearson; C R Darby; A R Bushell; L J West; P J Morris; K J Wood
Journal:  Transplantation       Date:  1993-02       Impact factor: 4.939

8.  Microchimerism frequency two to thirty years after cadaveric kidney transplantation.

Authors:  S Caillat-Zucman; C Legendre; C Suberbielle; C Bodemer; L H Noël; H Kreis; J F Bach
Journal:  Hum Immunol       Date:  1994-09       Impact factor: 2.850

9.  Induction of immunity and oral tolerance with polymorphic class II major histocompatibility complex allopeptides in the rat.

Authors:  M H Sayegh; S J Khoury; W W Hancock; H L Weiner; C B Carpenter
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

10.  Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation.

Authors:  T E Starzl; A J Demetris; M Trucco; A Zeevi; H Ramos; P Terasaki; W A Rudert; M Kocova; C Ricordi; S Ildstad
Journal:  Transplantation       Date:  1993-06       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.